648904-48-7

Basic information

• Product Name: Piperidine, 1-[2-[4-[[6-methoxy-2-(phenylmethoxy)-1-naphthalenyl]oxy]phenoxy]ethyl] -
• CAS NO: 648904-48-7
• Molecular Formula: C31H33NO4
• Molecular Weight: 483.607
• Mol File: 648904-48-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Piperidine, 1-[2-[4-[[6-methoxy-2-(phenylmethoxy)-1-naphthalenyl]oxy]phenoxy]ethyl] -(CAS DataBase Reference)
• NIST Chemistry Reference: Piperidine, 1-[2-[4-[[6-methoxy-2-(phenylmethoxy)-1-naphthalenyl]oxy]phenoxy]ethyl] -(648904-48-7)
• EPA Substance Registry System: Piperidine, 1-[2-[4-[[6-methoxy-2-(phenylmethoxy)-1-naphthalenyl]oxy]phenoxy]ethyl] -(648904-48-7)

Safety Data

• Hazardous Substances Data: 648904-48-7(Hazardous Substances Data)

Upstream product

• 648904-47-6 2-(benzyloxy)-1-bromo-6-methoxynaphthalene 
• 100238-42-4 4-(2-piperidin-1-yl-ethoxy)-phenol 

Downstream Products

• 648905-66-2 4-{6-methoxy-1-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-yl}-N,N-dimethylbenzenesulfonamide 
• 862129-77-9 (+/-)-6-(4-methanesulfonyl-cyclohex-1-enyl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol 
• 862130-04-9 6-(1,1-dioxo-hexahydro-1λ6-thiopyran-4-yl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol 
• 862129-85-9 6-(1,1-dioxo-1,2,3,6-tetrahydro-1λ6-thiopyran-4-yl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol 
• 861930-36-1 6-(3-fluoro-phenyl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol 
• 862081-59-2 4-{6-hydroxy-1-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-yl}-N,N-dimethyl-benzamide 
• 648905-29-7 5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-6-[4-(propane-2-sulfonyl)-phenyl]-naphthalen-2-ol 
• 648904-79-4 6-(4-ethanesulfonyl-phenyl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol 
• 770708-13-9 4-{6-hydroxy-1-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-yl}-N,N-dimethylbenzenesulfonamide 
• 862129-75-7 (+/-)-1-(2-{4-[2-(4-methanesulfonyl-cyclohex-1-enyl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine 
• 862129-82-6 1-(2-{4-[2-(1,1-dioxo-1,2,3,6-tetrahydro-1λ6-thiopyran-4-yl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine 
• 862130-05-0 6-(4-methanesulfonyl-cyclohexyl)-5-[4-(2-piperidin-1-yl-ethoxy)-phenoxy]-naphthalen-2-ol 
• 862129-83-7 1-(2-{4-[2-(3,6-dihydro-2H-thiopyran-4-yl)-6-methoxy-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine 
• 946077-40-3 C₃₀H₂₉NO₃F₂ 

Relevant articles and documents

SELECTIVE ESTROGEN RECEPTOR MODULATOR

The present invention is directed to a compound of the formula (A): or a pharmaceutically acceptable salt thereof; and also to compounds of formula (I): or a pharmaceutically acceptable salt thereof.

A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats

The design of a novel selective estrogen receptor modulator (SERM) for the potential treatment of uterine leiomyoma is described. 16 (LY2066948-HCl) binds with high affinity to estrogen receptors α and β (ERα and ERβ, respectively) and is a potent uterine

SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS

The present invention relates to a selective estrogen receptor modulator of formula I or Ia: (I) (Ia); or a pharmaceutical acid addition salt thereof; useful for treating vasomotor symptoms, in particular hot flashes, night sweats and other symptoms that affect women around menopause.